Intrinsic value of Century Therapeutics, Inc. (IPSC)

Live fair value data for Century Therapeutics, Inc. (IPSC) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Downside: -14.0%

Margin of Safety: -16.3%

Current Price: $163.00

Valuation: Overvalued

Confidence: 5.0/10

Visual Bar

Market Price $163.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Century Therapeutics, Inc. (IPSC) undervalued or overvalued?

Based on the current model output, Century Therapeutics, Inc. appears to be overvalued with a downside of 14.00%.

Fair value vs market price — Century Therapeutics, Inc. (IPSC)

Unlock premium access to view the live fair value comparison against current market price for IPSC.

Frequently Asked Questions - IPSC

How is IPSC intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for IPSC.

Is IPSC undervalued or overvalued right now?

IPSC is currently shown as overvalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for IPSC: open their intrinsic value pages.

Explore Other Stocks